PRIME GENESIS II PE SECONDARIES FUND SCSP Files Exempt Offering (3c7)
| Field | Detail |
|---|---|
| Company | Prime Genesis II Pe Secondaries Fund Scsp |
| Form Type | D |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $1, $1,000,000, $5,000,000, $1,000,001, $5,000,001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: exempt-offering, private-fund, capital-raise
TL;DR
**PRIME GENESIS II PE SECONDARIES FUND SCSP just filed a Form D for an exempt offering, targeting qualified purchasers.**
AI Summary
PRIME GENESIS II PE SECONDARIES FUND SCSP filed a Form D on March 24, 2026, indicating an exempt offering of securities. This filing specifically notes the fund operates under Section 3(c)(7) of the Investment Company Act, meaning it's a private investment fund for qualified purchasers. For investors, this matters because it signals the fund is raising capital from sophisticated investors, which can be a positive sign of institutional interest, but also means it's not accessible to the general public.
Why It Matters
This filing indicates PRIME GENESIS II PE SECONDARIES FUND SCSP is raising capital from qualified purchasers, signaling activity in the private investment space.
Risk Assessment
Risk Level: low — A Form D filing for an exempt offering generally carries low direct risk to existing public shareholders as it pertains to private capital raising.
Analyst Insight
Investors should note this filing indicates a private fund raising capital from qualified purchasers, which doesn't directly impact public market trading but shows activity in the private equity secondaries market.
Key Players & Entities
- PRIME GENESIS II PE SECONDARIES FUND SCSP (company) — the filer of the Form D
- 0002114884 (company) — the CIK (Central Index Key) for the filer
- Luxembourg (company) — the location of the filer's mailing and business address
FAQ
What type of filing is this document?
This document is a Form D, which is a 'Notice of Exempt Offering of Securities' filed by PRIME GENESIS II PE SECONDARIES FUND SCSP.
When was this Form D filed and accepted by the SEC?
The Form D was filed and accepted by the SEC on March 24, 2026, at 14:30:34.
Under which specific section of the Investment Company Act does this fund operate?
This fund operates under Section 3(c)(7) of the Investment Company Act, as indicated by 'Item 3C.7: Section 3(c)(7)' in the filing.
What is the business address of PRIME GENESIS II PE SECONDARIES FUND SCSP?
The business address of PRIME GENESIS II PE SECONDARIES FUND SCSP is 8, RUE LOU HEMMER, LUXEMBOURG, Luxembourg L-1748.
What is the CIK number for the filer, PRIME GENESIS II PE SECONDARIES FUND SCSP?
The CIK number for PRIME GENESIS II PE SECONDARIES FUND SCSP is 0002114884.
Filing Stats: 1,211 words · 5 min read · ~4 pages · Grade level 16.3 · Accepted 2026-03-24 14:30:34
Key Financial Figures
- $1 — enues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,
- $1,000,000 — No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,
- $5,000,000 — Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001
- $1,000,001 — e $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
- $5,000,001 — $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
- $25,000,000 — $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001
- $25,000,001 — $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
- $50,000,000 — 5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,0
- $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $1
- $50,000,001 — 0,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 O
Filing Documents
- primary_doc.html (D)
- primary_doc.xml (D) — 6KB
- 0002114884-26-000001.txt ( ) — 7KB
From the Filing
Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership Limited Liability Company General Partnership Business Trust Other Name of Issuer PRIME GENESIS II PE SECONDARIES FUND SCSP Jurisdiction of Incorporation/Organization LUXEMBOURG Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2025 Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer PRIME GENESIS II PE SECONDARIES FUND SCSP Street Address 1 Street Address 2 8, RUE LOU HEMMER Senningerberg LUXEMBOURG L-1748 +352 24 61 60 66 55 3. Related Persons Last Name First Name Middle Name PRIME GENESIS II PE SECONDARIES GP S.A R.L. N/A Street Address 1 Street Address 2 8, rue Lou Hemmer Senningerberg LUXEMBOURG L-1748 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) General Partner of the Issuer 4. Industry Group Agriculture Banking & Financial Services Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes No Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology Computers Telecommunications Other Technology Travel Airlines & Airports Lodging & Conventions Tourism & Travel Services Other Travel Other 5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 Over $100,000,000 Decline to Disclose Decline to Disclose Not Applicable Not Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b) Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7) 7. Type of Filing New Notice Date of First Sale 2026-03-18 First Sale Yet to Occur Amendment 8. Duration of Offering Does the Issuer intend this offering to last more than one year? Yes No 9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe) 10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? Yes No Clarification of Response (if Necessary) 11. Minimum Investment Minimum investment accepted from any outside investor $ 0 USD 12. Sales Compensation Recipient Recipient CRD Number None EVERCORE GROUP L.L.C. 42405 (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number None Street Address 1 Street Address 2 55 EAST 52ND STREET New York NEW YORK 10055 13. Offering and Sales Amounts Total Offering Amount $ USD Indefinite Total Amount Sold $ 486603100 USD Total Remaining to be Sold $ USD Indefinite Clarification of Response (if Necessary) 14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who al